# RAP2B

## Overview
RAP2B is a gene that encodes the RAP2B protein, a member of the Ras superfamily of small GTPases, which are pivotal in signal transduction processes. The RAP2B protein functions as a molecular switch, cycling between active and inactive states, and is involved in various cellular processes, including cell adhesion, polarity, and proliferation. It is characterized by specific structural motifs, such as the GTP/GDP binding motif and a CAAX motif, which facilitate its membrane localization and function (Zhu2024Inhibiting; Gloerich2011Regulating). The protein undergoes post-translational modifications, such as S-palmitoylation, which are crucial for its role in cell migration and invasion (Zhu2024Inhibiting). RAP2B is implicated in cancer progression, with altered expression linked to enhanced cell proliferation and migration in various cancers, making it a potential therapeutic target (Zhu2020Rap2B; Di2015Rap2B).

## Structure
The RAP2B protein is a member of the Ras superfamily of small GTPases, which are involved in signal transduction processes. The primary structure of RAP2B includes a sequence of amino acids that form specific motifs essential for its function. Notably, it contains a GTP/GDP binding motif, which is crucial for its role as a molecular switch cycling between active and inactive states (Gloerich2011Regulating). The protein also features a CAAX motif at the C-terminus, which is involved in lipid modifications such as palmitoylation and prenylation, aiding in its membrane localization (Zhu2024Inhibiting).

The secondary structure of RAP2B likely includes alpha helices and beta sheets, typical of small GTPases, although specific details are not provided in the context. The tertiary structure forms a compact, globular shape, allowing interactions with other proteins. RAP2B undergoes post-translational modifications, including S-palmitoylation at cysteine residues C176 and C177, which is critical for its localization to the plasma membrane and its function in cell migration and invasion (Zhu2024Inhibiting).

RAP2B may also exist in splice variant isoforms, which could alter its functional properties, although specific variants are not detailed in the provided context. The protein's structure and modifications are integral to its role in cellular processes and cancer progression.

## Clinical Significance
RAP2B, a member of the RAS oncogene family, is implicated in the progression of several cancers due to its altered expression and interactions. In breast cancer, RAP2B is overexpressed, leading to enhanced cell proliferation, migration, and invasion through the calcium-related ERK1/2 signaling pathway. Knockdown of RAP2B in breast cancer cells results in reduced proliferation and migration, suggesting its potential as a therapeutic target (Di2015Rap2B).

In hepatocellular carcinoma (HCC), RAP2B is upregulated and functions as an oncogene. Its silencing reduces cell proliferation and invasion while increasing apoptosis. This is linked to the inactivation of the PTEN/PI3K/Akt and ERK1/2 pathways, which are crucial for cancer cell survival and proliferation (Zhu2020Rap2B).

RAP2B also plays a significant role in glioma, where its overexpression is associated with increased tumor grade and poor prognosis. It promotes glioma cell proliferation and migration via the ERK pathway, and its knockdown reduces these oncogenic activities (Shi2021Rap2B).

In pancreatic cancer, RAP2B is part of the TMEM43/PRPF3/RAP2B/ERK axis, contributing to tumor growth and metastasis. Silencing RAP2B decreases cell proliferation and invasion, highlighting its role in cancer progression (Li2022TMEM43).

## Interactions
RAP2B, a member of the RAS oncogene family, is involved in various protein interactions that regulate its activity and function. It is regulated by guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs), which control its activation and inactivation. These interactions are crucial for RAP2B's role in cellular processes such as cell adhesion, cell polarity, and proliferation (Gloerich2011Regulating).

RAP2B interacts with effector proteins that typically contain Ras/Rap-binding domains. These interactions are essential for its signaling pathways, which are distinct from those of other Rap proteins due to specific binding domains that differentiate between Rap1 and Rap2 (Gloerich2011Regulating). The regulation of RAP2B is influenced by its localization to various membrane compartments, mediated by lipid modifications in its C-terminal tail (Gloerich2011Regulating).

RAP2B is also involved in pathways mediated by Epac proteins, which are cAMP-regulated GEFs that activate Rap proteins, including RAP2B. These pathways influence cardiac gene expression and function, highlighting RAP2B's role in cardiac calcium homeostasis and prohypertrophic gene transcription (Schmidt2013Exchange).


## References


[1. (Zhu2020Rap2B) Linchao Zhu, Ying Sun, Shufeng Zhang, and Lin Wang. Rap2b knockdown suppresses malignant progression of hepatocellular carcinoma by inactivating the pten/pi3k/akt and erk1/2 pathways. Molecular and Cellular Biochemistry, 466(1–2):55–63, February 2020. URL: http://dx.doi.org/10.1007/s11010-020-03687-w, doi:10.1007/s11010-020-03687-w. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s11010-020-03687-w)

[2. (Li2022TMEM43) Junqiang Li, Yang Song, Chao Zhang, Ronglin Wang, Lei Hua, Yongdong Guo, Dongxue Gan, Liaoliao Zhu, Shanshan Li, Peixiang Ma, Cheng Yang, Hong Li, Jing Yang, Jingjie Shi, Xiaonan Liu, and Haichuan Su. Tmem43 promotes pancreatic cancer progression by stabilizing prpf3 and regulating rap2b/erk axis. Cellular &amp; Molecular Biology Letters, March 2022. URL: http://dx.doi.org/10.1186/s11658-022-00321-z, doi:10.1186/s11658-022-00321-z. This article has 14 citations.](https://doi.org/10.1186/s11658-022-00321-z)

[3. (Gloerich2011Regulating) Martijn Gloerich and Johannes L. Bos. Regulating rap small g-proteins in time and space. Trends in Cell Biology, 21(10):615–623, October 2011. URL: http://dx.doi.org/10.1016/j.tcb.2011.07.001, doi:10.1016/j.tcb.2011.07.001. This article has 132 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.tcb.2011.07.001)

[4. (Schmidt2013Exchange) Martina Schmidt, Frank J. Dekker, and Harm Maarsingh. Exchange protein directly activated by camp (epac): a multidomain camp mediator in the regulation of diverse biological functions. Pharmacological Reviews, 65(2):670–709, February 2013. URL: http://dx.doi.org/10.1124/pr.110.003707, doi:10.1124/pr.110.003707. This article has 223 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1124/pr.110.003707)

[5. (Di2015Rap2B) Jiehui Di, Hui Huang, Debao Qu, Juangjuan Tang, Wenjia Cao, Zheng Lu, Qian Cheng, Jing Yang, Jin Bai, Yanping Zhang, and Junnian Zheng. Rap2b promotes proliferation, migration and invasion of human breast cancer through calcium-related erk1/2 signaling pathway. Scientific Reports, July 2015. URL: http://dx.doi.org/10.1038/srep12363, doi:10.1038/srep12363. This article has 71 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/srep12363)

[6. (Zhu2024Inhibiting) Jiangli Zhu, Xize Cao, Zhenshuai Chen, Birou Lai, Lingling Xi, Jinghang Zhang, Shaohui Zhu, Shiqian Qi, Yinming Liang, Fei Cao, Binhui Zhou, Yu Song, Sheng Jiang, Tianyu Wang, Xiaohong Kang, and Eryan Kong. Inhibiting s-palmitoylation arrests metastasis by relocating rap2b from plasma membrane in colorectal cancer. Cell Death &amp; Disease, September 2024. URL: http://dx.doi.org/10.1038/s41419-024-07061-2, doi:10.1038/s41419-024-07061-2. This article has 0 citations.](https://doi.org/10.1038/s41419-024-07061-2)

[7. (Shi2021Rap2B) Guohong Shi and Zhen Zhang. Rap2b promotes the proliferation and migration of human glioma cells via activation of the erk pathway. Oncology Letters, February 2021. URL: http://dx.doi.org/10.3892/ol.2021.12575, doi:10.3892/ol.2021.12575. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ol.2021.12575)